An Interactive Case Review

Through expert analysis of current treatment paradigms, this CME program will provide a comprehensive review of treatment advances in the management of Renal Cell Carcinoma (RCC) and will discuss current and emerging treatment options for patients with RCC.

Current and Evolving Treatment Options in RCC Robert J. Motzer, MD Memorial Sloan-Kettering Cancer Center Weil Medical College of Cornell University New York, NY Topics include: Current treatment of Advanced/Metastatic RCC Rationale for mTOR inhibitors in RCC mTOR inhibitor clinical trials in RCC single agent therapy combination therapy

Case Studies in Treatment of Advanced RCC Gary R. Hudes, MD Senior Member, Genitourinary Malignancies Program Fox Chase Cancer Center Topics include: Targeted therapies for treatment of Advanced RCC Patient Case Study 1 Patient Case Study 2

Available until December 2010, this activity offers:
Physicians: 1.0 AMA PRA Category 1 Credits^™
Nurses: 1.0 contact hours
Pharmacists: 1.0 contact hours (0.1 CEUs)

This activity is made possible by an educational grant from:
 

 

[Back to top]

[Back to Activity Home]